in vitro [7] and monocyte/macrophages in vivo [8, 9] and glomerulonephropathy with crescents (N ϭ 1) was studied by has been described in a number of models of injury in immunohistochemistry, in situ hybridization, and combined immunohistochemistry/in situ hybridization. Additionally, antiassociation with accumulations of macrophages in tissue bodies to cell-specific phenotypic markers were used to identify [10] [11] [12] [13] [14] [15] . In some settings, osteopontin may act as a cell cellular components of the glomerular crescent, which express survival factor for renal cells [13, 16] .
osteopontin protein and mRNA.
These chemotactic and trophic features of osteopontin,
Results. All of the crescents present in the biopsies studied in addition to its up-regulation in the tubulointerstitium contained a significant number of cells that expressed osteoponin a variety of rodent models of renal injury [11, 12, 14, 15, tin protein and mRNA, demonstrated by immunohistochemistry and in situ hybridization, respectively. Using replicate tissue [17] [18] [19] , suggest that osteopontin could be an important sections and combined immunohistochemistry/in situ hybridmediator of the glomerular injury that occurs in cresization, we showed that the majority of the strongly osteoponcentic glomerulonephritis. It is generally accepted that 
ies have demonstrated the expression of osteopontin in
Conclusions. Macrophages present in the human glomerular crescent express osteopontin protein and mRNA at a high crescentic glomeruli [20] . In this model, osteopontin aplevel. This expression supports a role for osteopontin in the peared to be expressed predominantly by visceral and formation and progression of the crescentic lesion via chemoparietal epithelial cells, and this expression preceded mactactic and signaling properties of the molecule.
rophage influx [20] . Most infiltrating monocytes/macrophages had no demonstrable osteopontin expression in this model. In further studies in the same rat model, pontin for the evolution of the disease process.
We sought to extend these observations in rodents to [32] corresponding human disease. We did this by examining osteopontin has been characterized by Western blotting, the expression of osteopontin mRNA and protein in and its ability to detect osteopontin by immunocytochemhuman renal biopsies demonstrating crescentic glomeruistry in fixed tissue sections has been previously demonlonephritis. In glomeruli involved by crescent formation, strated [5, 23, 24] . Further demonstration of the specificwe demonstrate that osteopontin is expressed by cells ity of this antibody comes from previous complementary localized both within areas of the urinary space involved studies that localize expression of osteopontin mRNA by crescents and within the glomerular tufts. Further to sites of peptide expression in tissue sections [25] . characterization of the cells expressing osteopontin Monocytes/macrophages. PGM1 (Dako, Carpenteria, mRNA demonstrates that a majority of these cells are CA, USA) is a well-characterized murine monoclonal monocyte/macrophages. These studies provide clear eviantibody directed against the CD68 epitope present on dence that osteopontin is present and may participate human monocytes and macrophages. Its specificity has in the events of crescentic glomerulonephritis but that been demonstrated by Western blotting, and it has been important differences in patterns of osteopontin expresshown to be reactive in formalin-fixed, paraffin-embedsion may exist between human disease and rodent modded tissue following antigen retrieval [26] . els. These mechanistic differences could limit the appli-HAM56 (Dako) is a murine monoclonal IgM that is cability of therapeutic approaches targeting osteopontin reactive with human monocytes and macrophages and also derived from animal models of crescentic glomerulonedemonstrates cross-reactivity with endothelial cells [27] . phritis to the treatment of analogous human disease.
␣-Smooth muscle actin. 1A4 (Dako) is a murine monoclonal antibody specific for ␣-smooth muscle actin [28] .
METHODS
It has been extensively characterized by Western blotting Tissue and has been previously shown to identify smooth muscle actin in methyl Carnoys and formalin-fixed tissue using Core needle biopsies were obtained from the University of Washington Medical Center. Biopsies that had immunohistochemical procedures [29, 30] . been diagnosed as crescentic glomerulonephritis (N ϭ 19), Podocytes. P27 kip1 (p27; Santa Cruz Biotechnology, IgA nephropathy with crescents (N ϭ 2), and diffuse prolifSanta Cruz, CA, USA) is an affinity-purified goat polyerative lupus glomerulonephritis with crescents (N ϭ 1) clonal antibody raised against peptides corresponding to were studied. As controls, biopsies of diabetic nephropaamino acids 181 to 298 at the carboxy terminus of human thy (N ϭ 2), membranous glomerulonephritis (N ϭ 2), p27. It has been characterized by Western blotting and IgA nephropathy without crescents (N ϭ 5), and protoimmunoprecipitation and has been shown to immunolocol transplant biopsies (N ϭ 6) were used. Additional calize to the nuclei of human podocytes [31] . control tissue consisted of macroscopically normal ap-WT-1 (C-19) is a rabbit polyclonal antibody that reacts pearing cortex taken from kidneys resected for localized with the Wilms Tumor antigen. It has been characterized neoplasms (N ϭ 4). All of the surgical tissue specimens by Western blotting and immunoprecipitation. WT-1 has were fixed in 10% neutral buffered formalin. In addition, been shown to react with both fetal and adult visceral six cases of crescentic glomerulonephritis fixed in methyl epithelial cells [32] . Carnoys solution (60% methanol, 30% chloroform, 10%
T cells used in this study were CD3 (Dako), an affinityacetic acid) were utilized. All fixed tissues were propurified rabbit polyclonal raised against synthetic human cessed and embedded in paraffin according to standard CD3 peptide. This antibody reacts with the T-lymphoprotocols.
cyte to proceed overnight at 50ЊC. After hybridization, secImmunohistochemistry tions were washed with 0.5 ϫ SSC, treated with RNase A (20 g/mL, 30 minutes at room temperature), washed Both formalin-and methyl Carnoys-fixed, paraffinembedded tissue sections were deparaffinized, rehydrated, in 2 ϫ SSC (2 ϫ 2 min), followed by three high stringency washes in 0.1 ϫ SSC/0.1% Tween 20 (Sigma) at 55ЊC and then incubated in 3% hydrogen peroxide to block endogenous peroxidases. For antibodies requiring antiand several 2 ϫ SSC washes, dehydrated, and air dried. The slides hybridized with the 35 S-labeled probe were gen retrieval (Table 1) , the tissue sections were immersed in Antigen Retrieval Solution (Vector Laboratories, Burdipped in NTB2 nuclear emulsion (Kodak, Rochester, NY, USA) and exposed in the dark at 4ЊC for three to 10 lingame, CA, USA) that had been preheated to 95ЊC and then heated for 30 minutes in a household vegetable days. After developing, the sections were counterstained with hematoxylin and eosin and were dehydrated, steamer. Following steam heating, the slides were allowed to cool for 20 minutes at room temperature and were mounted, and viewed. Positive cellular labeling was dewashed in phosphate-buffered saline (PBS). The sections fined as five or more silver grains concentrated over a were then incubated sequentially with 10% normal sesingle cell. rum (only used for polyclonal antibodies to block nonspeNegative controls included hybridization performed cific binding), primary antibody, biotinylated secondary on replicate tissue sections using the sense riboprobe. antibody (Vector Laboratories), and the avidin-biotinCombined immunohistochemistry and horseradish peroxidase (HRP) complex (ABC; Vector).
in situ hybridization The immunohistochemical signal was then visualized with 3,3Ј-diaminobenzidine (Sigma, St. Louis, MO, USA) Slides were first hybridized and washed as discussed with nickel chloride enhancement to give a black-brown earlier in this article. Following the in situ hybridization reaction product. After methyl green counterstaining, stringency washes, the slides were incubated with prithe slides were dehydrated and coverslipped. For all mary antibody (PGM1 HAM56, AE1/AE3, or 1A4) for samples, negative controls for the immunohistochemisone hour at room temperature. After washing, the slides try included substitution of the primary with antibody were incubated with HRP-conjugated secondary antian irrelevant IgG from the same species (Dako).
body, and then DAB without nickel chloride enhancement was used to produce a brown reaction product.
In situ hybridization
Following immunostaining, the slides were washed, deHuman osteopontin cDNA in plasmid pBluescript hydrated, and then dipped in NTB-2 emulsion. SK(Ϫ) (plasmid OP-10) was obtained from Dr. Larry Fisher (National Institutes of Health) [39] . It contains a RESULTS 1493 bp fragment of the human osteopontin gene, which A total of 22 biopsies containing crescentic glomeruli includes the entire protein-encoding sequence of the huwere studied by immunocytochemistry and in situ hyman osteopontin Ia gene. The plasmid was linearized bridization. This included 19 cases of segmentally necrowith Xba 1 and Xho 1 and then transcribed into both tizing and crescentic glomerulonephritis of nonimmune antisense and sense (negative control) riboprobes using complex type, two cases of IgA nephropathy with cresreagents from Promega (Madison, WI, USA), except cents, and one case of diffuse proliferative lupus glomer-35 S UTP, which was obtained from NEN (Boston, MA, ulonephritis. An additional six cases of crescentic glo-USA). The details of this procedure have been premerulonephritis, which had been fixed in methyl Carnoys viously published [40] . Needle biopsy kidney tissue, solution, were studied by immunohistochemistry. There which had been fixed in 10% formalin and embedded in was a total of 110 crescentic glomeruli present, which paraffin, was deparaffinized following standard protocol.
were primarily cellular (N ϭ 43) and fibrocellular (N ϭ The sections were washed with 0.5 ϫ standard saline 67) in composition (Table 2) . Crescentic glomeruli were citrate (SSC; 1 ϫ SSC ϭ 150 mmol/L NaCl, 15 mmol/L Na citrate, pH 7.0) and digested with 10 g/mL proteinase sorted based on their morphologic appearance in a rou- (Figs. 1B, 2B , and 3 C, D). Localization of osteopontin protein by immunocytochemistry in replipeared to be composed of organized layers of cells, cate sections demonstrated a similar pattern of expreswhereas fibrocellular crescents were composed of a mixsion (Fig. 1A, 2A , and 3A) with both weak to moderate ture of cells and extracellular matrix. expression in the crescent and strong expression by indiGlomerular osteopontin expression vidual cells. Using combined immunohistochemistry and in situ hybridization, osteopontin protein and mRNA All of the tissues, both methyl Carnoys and formalin were localized to the same cells present in the crescentic fixed, were utilized for immunohistochemistry. Addiglomeruli (data not shown). Morphologically normal aptionally, all of the formalin-fixed specimens were used for pearing glomeruli within the same biopsies generally did in situ hybridization to demonstrate osteopontin mRNA not contain osteopontin expressing cells, although an expression. A majority of the crescentic glomeruli were occasional circulating cell could be seen within the gloshown to express osteopontin protein by immunocytomerular tuft or closely opposed to Bowman's capsule, chemistry. This expression was usually localized to indiwhich did express osteopontin mRNA (Fig. 4 A, C, D) vidual cells within the crescent, as well as to cells within or protein (Fig. 5 A, B) . Occasional osteopontin mRNA the glomerular tuft (Fig. 1A) . Rarely, a strong, more expressing cells could also be seen in periglomerular diffuse extracellular pattern of expression could be seen inflammatory infiltrates (Fig. 4 C, D) . Tubular expression distributed over the crescentic lesion (Fig. 2A) . The most of osteopontin mRNA and protein was widespread (Figs. common pattern of expression seen is shown in Figure  1 -6) and was expressed by both proximal and distal tu-3A, with individual cells expressing a high level of osteobules. Glomeruli of the nondiseased adult kidney, dispontin protein, as well as moderate expression spread eased kidneys without crescent formation, and kidneys throughout the crescent. In the noncrescentic control undergoing transplant rejection did not contain any ostissues, there was no osteopontin protein localized to teopontin-positive cells demonstrated by either in situ glomeruli (data not shown).
hybridization or immunocytochemistry, although tubuAs can be seen in Table 2 , all of the crescentic glomerlar expression remained widespread. uli contained cells that expressed osteopontin mRNA.
Phenotype of osteopontin-expressing cells In many cases, there were distinct osteopontin mRNApositive cells within the residual glomerular tuft as well Cellular crescents are known to contain several different cell types, including glomerular epithelial cells, macas a weak, more diffuse hybridization signal spread over rophages, lymphocytes. As the crescent progresses to a more fibrous state, fibroblasts or myofibroblasts may infiltrate from the interstitium. Because osteopontin mRNA signal localized to cells within both the crescent (CD68 and Ham56), T cells (CD3), vascular cell adhesion molecule (VCAM; CD106), p27 and Wilms tumor antigen (WT-1), and also hybridized with the osteopontin was parietal epithelial cells, which normally express these riboprobe. All of the crescentic glomeruli contained a markers. In some of the fibrocellular crescents, ␣-smooth significant number of CD68-positive macrophages (2-30 muscle actin-expressing myofibroblasts could also be CD68ϩ macrophages/crescentic glomerulus, median ϭ identified (data not shown). The expression of WT-1 8.9; Table 2 ). The expression of CD3-positive T cells was and p27, markers of mature visceral epithelial cells, was less frequent (0 to 3 per crescentic glomerulus). Many largely absent in the crescents. As can be seen in Figures crescents also contained cytokeratin-expressing cells 3 and 4, the cell-specific pattern of osteopontin expres- (Fig. 6 E, F) and VCAM-expressing cells (data not shown), indicating that a major component of these crescents sion appeared to match that of the macrophage marker CD68 closely. Because of the complexity of composition DISCUSSION of the cellular and fibrocellular crescentic lesions, it was
In this study, we retrospectively examined 25 cases of impossible to positively identify the cells that express crescentic glomerulonephritis, 2 cases of IgA nephropaosteopontin using serially sectioned slides.
thy with crescents, and 1 case of diffuse proliferative Therefore, to more accurately identify the cells within lupus glomerulonephritis with crescents for the presence the crescent, which express osteopontin, combined imof osteopontin. In all of the cases studied, there was munohistochemistry and in situ hybridization were persignificant expression of osteopontin protein and mRNA formed on a subset of the biopsies. As can be seen in within the crescentic and segmentally sclerotic glomeruli, Figure 6 A-D, the majority of cells that demonstrated as well as rare expression within histologically normalstrong hybridization signal with the osteopontin riboappearing glomeruli. In noncrescentic control biopsies, probe were monocytes/macrophages, as demonstrated no osteopontin expression could be identified in glomerby their colabeling with both the Ham56 and CD68 antiuli. This finding is in agreement with previously pubbodies. Interestingly, monocytes and macrophages preslished results [25] , in which we found osteopontin exent in the tubulointerstitium (Fig. 6 G, H) did not appear pressed only in tubular epithelium of mature adult kidney. to be positive for osteopontin mRNA expression. AlOsteopontin protein and mRNA expression demonthough not every cell that showed positive osteopontin strated a similar pattern of expression, with both weak hybridization signal could be definitively identified as a to moderate expression spread throughout the crescent macrophage, none of the osteopontin mRNA-positive and very strong expression by individual cells. Rarely, cells were colabeled with AE1/AE3 (anticytokeratin; immunohistochemistry demonstrated strong osteopon- Fig. 5 E, F) , anti-␣-smooth muscle actin (data not tin protein expression throughout the crescent, as shown shown), or anti-CD3 (data not shown), that might indiin Figure 2 . In this case, however, osteopontin mRNA cate cells of epithelial, myofibroblast, or lymphocyte oriexpression was limited to individual cells present in the glomerular tuft, suggesting that the osteopontin protein gin, respectively. was secreted by these cells and may have been bound localized to individual cells present in the crescent, or it could represent a very low level of osteopontin mRNA to cells or extracellular matrix present in the crescent. The generally weak hybridization signal seen spread difexpression in a number of cells present in the crescents. The majority of the osteopontin-expressing cells presfusely in the crescents by in situ hybridization with the osteopontin riboprobe is difficult to interpret. It may be ent within the glomeruli in the crescentic biopsies are monocyte/macrophages, as identified by immunostaining background due to the very strong hybridization signal of replicate tissue sections and by combined in situ hybridization and immunohistochemistry. None of the osteopontin mRNA-positive cells could be identified as T cells, cytokeratin expressing epithelial cells or ␣-smooth muscle actin positive myofibroblasts. However, because of sensitivity limitations associated with the combined immunohistochemistry and in situ hybridization technique, we cannot exclude the possibility that osteopontin mRNA is expressed, perhaps at a lower level, by other cell types present in the crescent.
These results are in contrast to those reported recently in a rodent model of anti-GBM crescentic glomerulonephritis [20, 21] . In this rat model, osteopontin expression appeared to localize predominantly to intrinsic renal epithelial cells and preceded the influx of macrophages.
Although the biopsies of human crescentic glomerulonephritis (GN) undoubtedly represent a more chronic stage of disease than that examined in the rodent model, within each biopsy, glomeruli could be seen that represented different stages of crescent formation. Even in very small, cellular crescents composed of two to three layers of cells, CD68-positive monocyte/macrophages were present, and it was these cells in which osteopontin expression could be detected. Additionally, in a number of cases with features of crescentic glomerulonephritis, histologically normal-appearing glomeruli demonstrated rare osteopontin-producing cells closely opposed to Bowman's capsule, which were shown, upon double labeling and in replicate tissue sections, to be CD68-positive macrophages. These may represent the very earliest stage of crescent formation. There was no significant difference in the average number of osteopontin-positive cells between cellular and fibrocellular crescents ( Table 2 ). The total number of osteopontin mRNA expressing cells appeared rather to vary from one individual to another and not between different crescents within the same individual. Globally sclerotic glomeruli, which were generally devoid of cells, did not demonstrate significant osteo- models of crescentic GN that CD4ϩ T cells are essential signaling pathway to contribute to the pathogenesis of the crescentic lesion further. for the development of crescents. This has been demonIn this study, we have examined a series of human strated both in depletion studies using monoclonal anticrescentic GN biopsies for the expression of osteopontin. bodies [43] cells from apoptosis [16] . NF-B belongs to a family of 358, 1998 transcription factors that are involved in the up-regula- 
